The article says a comprehensive medical evaluation covering blood glucose, lipids, kidney function and cardiovascular history should be conducted before any GLP-1 treatment begins during perimenopause
They are FDA-approved for specific conditions, have controlled dosages, and cause minimal side effects
Statistical analyses Data are expressed as scattered plots or means +/ standard error (SE) or standard error of the mean (SEM)
Key issues include: No FDA approval for cosmetic tanning Inconsistent quality and sourcing Lack of standardized dosing Limited long-term safety data Medical professionals strongly caution against: Self-administration Products purchased online or from unregulated sources Read more: Peptide Therapy for Depression: Can CJC-1295 and BPC-157 Improve Mental Health
Key Takeaways The FDA recently approved Zepbound as a targeted therapy for obstructive respiratory conditions
Ultimately, the success of any neuron-, microglia-, or astrocyte-based intervention hinges on reliable outcome measurement tools